- Home
- PHAT vs SD Comparison
PHAT vs SD Comparison
Compare PHAT & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHAT | SD |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.6M | 505.0M |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PHAT | SD |
|---|---|---|
| Price | $6.92 | $14.27 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $20.09 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 321.4K |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 3.74% |
| EPS Growth | ★ 42.72 | 12.43 |
| EPS | N/A | ★ 1.22 |
| Revenue | ★ $175,110,000.00 | N/A |
| Revenue This Year | $80.58 | $25.99 |
| Revenue Next Year | $56.62 | N/A |
| P/E Ratio | ★ N/A | $11.40 |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $6.52 | $11.20 |
| 52 Week High | $18.31 | $18.45 |
Technical Indicators
Market Signals| Indicator | PHAT | SD |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 55.69 |
| Support Level | $6.91 | $13.84 |
| Resistance Level | $9.74 | $14.47 |
| Average True Range (ATR) | 0.37 | 0.31 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 47.08 | 88.52 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. The company's primary areas of operation are the Mid-Continent in Oklahoma and Kansas.